Elsevier’s Oncology Journal Network Highlights | Elsevier
Welcome to our Elsevier’s Oncology Journal Network Highlights page
Welcome to our Elsevier’s Oncology Journal Network Highlights page
Data from the phase 3 CRC-PREVENT trial support the sensitivity of ColoSense in the detection of colorectal cancer.
Diepstraten et al. demonstrate that p53 enforces apoptosis induced by BH3-mimetic drugs. To boost BH3-mimetic-induced apoptosis in TP53-mutant blood cancers, STING agonists were employed to induce…
One of the first HPV self-collection solutions has been approved by the FDA, which can identify women at risk of developing cervical cancer.
An abstract is unavailable.
The 2024 ASTRO Annual Meeting will be held at the Walter E. Washington Convention Center, Washington, DC, and virtually September 29-October 2, 2024.
Precursor conditions are early phases of diseases that may develop into cancers such as lymphoma, leukemia, and multiple myeloma.
NOTCH3 signaling activates tumor-associated mesenchymal cells, increases collagen production, and augments cell invasion in lung adenocarcinoma, suggesting its critical role in remodeling tumor stroma.
Abstract. Advances in cancer prevention, early detection and treatments have led to unprecedented progress against cancer. However, these advances have not benefited everyone equally. Because…
Through clinical research led by our Katy Rezvani, M.D., Ph.D., CAR NK cell therapy has now become an experimental treatment option for multiple cancers . Learn…
The FDA has approved one of the first human papillomavirus self-collection solutions for use in the US.